DE60212434D1 - Rosiglitazon-edisylate und ihre verwendung als antidiabetika - Google Patents

Rosiglitazon-edisylate und ihre verwendung als antidiabetika

Info

Publication number
DE60212434D1
DE60212434D1 DE60212434T DE60212434T DE60212434D1 DE 60212434 D1 DE60212434 D1 DE 60212434D1 DE 60212434 T DE60212434 T DE 60212434T DE 60212434 T DE60212434 T DE 60212434T DE 60212434 D1 DE60212434 D1 DE 60212434D1
Authority
DE
Germany
Prior art keywords
edisylates
antidiabetics
rosiglitazone
salt
ethanedisulfonicacid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60212434T
Other languages
English (en)
Other versions
DE60212434T2 (de
Inventor
Chien Ho
John Millan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0127931A external-priority patent/GB0127931D0/en
Priority claimed from GB0127933A external-priority patent/GB0127933D0/en
Priority claimed from GB0127932A external-priority patent/GB0127932D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE60212434D1 publication Critical patent/DE60212434D1/de
Publication of DE60212434T2 publication Critical patent/DE60212434T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60212434T 2001-11-21 2002-11-21 Rosiglitazon-edisylate und ihre verwendung als antidiabetika Expired - Fee Related DE60212434T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0127932 2001-11-21
GB0127933 2001-11-21
GB0127931 2001-11-21
GB0127931A GB0127931D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127933A GB0127933D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127932A GB0127932D0 (en) 2001-11-21 2001-11-21 Novel compounds
PCT/GB2002/005239 WO2003045947A1 (en) 2001-11-21 2002-11-21 Rosiglitazone edisylates and their use as antidiabetics

Publications (2)

Publication Number Publication Date
DE60212434D1 true DE60212434D1 (de) 2006-07-27
DE60212434T2 DE60212434T2 (de) 2007-05-24

Family

ID=27256332

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212434T Expired - Fee Related DE60212434T2 (de) 2001-11-21 2002-11-21 Rosiglitazon-edisylate und ihre verwendung als antidiabetika

Country Status (12)

Country Link
US (1) US20050107440A1 (de)
EP (1) EP1446404B1 (de)
JP (1) JP2005515987A (de)
KR (1) KR20040062965A (de)
CN (1) CN1612874A (de)
AT (1) ATE329914T1 (de)
AU (1) AU2002343052A1 (de)
DE (1) DE60212434T2 (de)
DK (1) DK1446404T3 (de)
ES (1) ES2266593T3 (de)
PT (1) PT1446404E (de)
WO (1) WO2003045947A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023803A1 (en) * 2003-09-10 2005-03-17 Biocon Limited Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
WO2007125385A2 (en) 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
JP2010529947A (ja) * 2006-12-22 2010-09-02 ベラス ヘルス（インターナショナル）リミテッド 代謝性疾患および糖尿病を治療するための方法、化合物、および組成物
KR20110015254A (ko) * 2009-08-07 2011-02-15 한미홀딩스 주식회사 프라수그렐 디술폰산염 및 이의 결정
CN101758337B (zh) 2009-12-03 2012-02-15 湖南阿斯达生化科技有限公司 一种助焊剂用非卤素活性剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7609666L (sv) * 1975-09-12 1977-03-13 Roussel Uclaf Sett att framstella nya 5-aminometyltiazolderivat
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
US20050107440A1 (en) 2005-05-19
WO2003045947A1 (en) 2003-06-05
DK1446404T3 (da) 2006-10-09
EP1446404A1 (de) 2004-08-18
DE60212434T2 (de) 2007-05-24
ES2266593T3 (es) 2007-03-01
KR20040062965A (ko) 2004-07-09
AU2002343052A1 (en) 2003-06-10
CN1612874A (zh) 2005-05-04
PT1446404E (pt) 2006-10-31
EP1446404B1 (de) 2006-06-14
ATE329914T1 (de) 2006-07-15
JP2005515987A (ja) 2005-06-02

Similar Documents

Publication Publication Date Title
IL155036A0 (en) Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
DE60212434D1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
AU2002343036A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DE60115062D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
DE60124119D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee